Citation
Rubenstein JH, Vakil N, Inadomi JM. The cost-effectiveness of biomarkers for predicting the development of oesophageal adenocarcinoma. Aliment Pharmacol Ther 2005 Jul 15;22(2):135-46 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/16011672.
Critical appraisals
Compare quality appraisals for each clinical question
- Are there useful biomarkers to detect and improve the diagnosis of neoplasia in patients with or without BO? (compare critical appraisals)
Cited by
Social links